PLAUR and neoplasm: CAR-T (chimeric antigen receptor T cell) cells engineered to target uPAR (uPAR–CAR-T) effectively ablated both senescent tumor cells and senescent stromal fibroblasts in preclinical models of liver and lung cancer [122].